JCI-accredited · 45+ hospitals & clinics · 90+ countries served · 24/7 multilingual support
General Health

Erythropoietin: A Complete Medical Overview

10 min read Published July 25, 2026
Modern hospital reception area with medical staff and patients.
Quick answer

Erythropoietin helps regulate red blood cell production in the bone marrow. The kidneys are the main source of erythropoietin in adults, especially when oxygen levels are low.

Key Takeaways

  • Erythropoietin helps regulate red blood cell production in the bone marrow.
  • The kidneys are the main source of erythropoietin in adults, especially when oxygen levels are low.
  • An erythropoietin test can help evaluate anemia or an unusually high red blood cell count.
  • Synthetic erythropoietin medicines may be used in selected patients, often in chronic kidney disease or some cancer-related situations.
  • Treatment aims to correct anemia safely while avoiding complications such as blood clots or excessively high hemoglobin levels.

Medically reviewed by the Acıbadem International Medical Board — July 20, 2026

Dr. Bahadır Kaynarkaya, MD Dr. Şule Eren, MD

Erythropoietin is a hormone, made mainly by the kidneys, that tells the bone marrow to produce red blood cells. It is important in understanding some forms of anemia, kidney disease, and conditions linked to unusually high red blood cell levels.

Overview: what erythropoietin is and why it matters

Erythropoietin is a natural hormone that helps the body make red blood cells. It is produced mainly by the kidneys and released when the body senses that tissues are not getting enough oxygen. In response, the hormone signals the bone marrow to increase red blood cell production, which improves oxygen delivery throughout the body.

This hormone is medically important for two main reasons. First, doctors measure erythropoietin levels when they are investigating anemia or an unusually high red blood cell count. Second, laboratory-made versions of erythropoietin can be used as medicines in carefully selected patients, especially when the body is not producing enough of its own.

Understanding erythropoietin helps connect several health issues that may seem unrelated at first. Kidney disease, chronic illness, some bone marrow disorders, and certain cancers can all affect how much erythropoietin is made or how well it works. For that reason, it is often discussed as part of a broader evaluation rather than as a stand-alone diagnosis.

How erythropoietin works in the body

How erythropoietin works in the body — erythropoietin

Red blood cells carry oxygen from the lungs to the tissues. When oxygen levels fall, specialized cells in the kidneys detect this change and increase erythropoietin production. The hormone then travels through the bloodstream to the bone marrow, where it stimulates the development of red blood cell precursors into mature red blood cells.

This feedback system is one of the body’s key ways of maintaining oxygen balance. If blood loss occurs, if a person lives at high altitude, or if a long-term illness reduces oxygen delivery, erythropoietin may rise to compensate. If the kidneys are damaged, however, they may not produce enough hormone, and anemia can develop even when the bone marrow itself is capable of making blood cells.

Erythropoietin does not work alone. Iron, vitamin B12, folate, and healthy bone marrow function are also needed for red blood cell production. This is why a person can have anemia even if erythropoietin is present, and why doctors often check several lab tests together rather than relying on one result.

When erythropoietin becomes clinically relevant

When erythropoietin becomes clinically relevant — erythropoietin

Erythropoietin commonly enters medical discussion when a person has symptoms or blood test results that suggest too few or too many red blood cells. Low red blood cell levels may lead to fatigue, weakness, shortness of breath, reduced exercise tolerance, pale skin, dizziness, or headaches. High red blood cell levels may cause headaches, flushing, visual symptoms, itching, or a higher risk of circulation-related complications.

One of the most common reasons for low erythropoietin is chronic kidney disease, because the kidneys are the main source of the hormone. In this setting, the body may not respond appropriately to anemia. Doctors may also consider erythropoietin in people being assessed for anemia, especially when the cause is not immediately clear.

High erythropoietin levels can occur when the body is trying to compensate for low oxygen, such as in chronic lung disease, sleep-disordered breathing, smoking, or living at high altitude. In some cases, increased erythropoietin may also be linked to rare tumors that produce the hormone. By contrast, a person with an abnormally high red blood cell count and a low erythropoietin level may have a bone marrow condition such as polycythemia.

Erythropoietin testing and diagnosis

An erythropoietin test is a blood test that measures the amount of the hormone in circulation. It is not usually ordered as a routine screen. Instead, it is used when a doctor needs more information about unexplained anemia or an increased red blood cell count. The result is interpreted together with a complete blood count, iron studies, kidney function tests, oxygen status, and sometimes bone marrow or genetic testing.

For anemia, the key question is whether the body is making an appropriate response. A low or inappropriately normal erythropoietin level may suggest that the kidneys are not producing enough hormone, which can happen in chronic kidney disease or some chronic inflammatory conditions. A high level may show that the body is trying to compensate, which can occur when anemia is due to blood loss, iron deficiency, or other causes outside the kidneys.

For a high red blood cell count, the test helps separate primary bone marrow causes from secondary causes. If erythropoietin is low, doctors may investigate whether the bone marrow is producing too many red blood cells on its own. If erythropoietin is high, they may look for chronic low oxygen states, kidney-related causes, or other conditions stimulating hormone production.

Test results should always be reviewed by a qualified clinician because interpretation depends on the full medical picture. A single erythropoietin value does not provide a diagnosis by itself, and normal ranges can vary by laboratory.

Medical treatment with erythropoietin

Laboratory-made forms of erythropoietin, often called erythropoiesis-stimulating agents, may be prescribed when the body does not produce enough of its own hormone. They are most often used in selected patients with anemia related to chronic kidney disease and in some people receiving certain cancer treatments. These medicines aim to reduce symptoms of anemia and, in some situations, reduce the need for blood transfusions.

Treatment is individualized. Before starting therapy, doctors usually look for treatable causes of anemia such as iron deficiency, bleeding, infection, inflammation, or deficiencies of vitamin B12 and folate. During treatment, blood counts are monitored regularly so that the response can be assessed and the risk of overcorrection minimized.

Erythropoietin-based treatment is not appropriate for every type of anemia. For example, if anemia is mainly due to iron deficiency, replacing iron may be more important than stimulating red blood cell production. In complex cases, care may involve kidney specialists, hematologists, and other clinicians, sometimes alongside supportive therapies such as blood transfusion or, when kidney failure is present, dialysis.

Patients should use these medicines only under medical supervision. Non-medical use can be dangerous because raising red blood cell levels too much can thicken the blood and increase the risk of serious complications.

Benefits, risks, and safe use

When used appropriately, erythropoietin treatment can improve symptoms related to anemia, such as tiredness and poor exercise tolerance. It may also help some patients avoid repeated transfusions. Even so, the goal is usually careful improvement rather than restoring blood counts as high as possible.

The main safety concern is that excessively high hemoglobin or red blood cell levels can increase the risk of blood clots, stroke, heart-related complications, and high blood pressure. Some patients may also have a limited response if they have ongoing inflammation, low iron stores, infection, or bone marrow disease. For this reason, clinicians monitor treatment closely and adjust it over time.

People with cancer may need especially careful discussion about benefits and risks, since treatment decisions depend on the type of cancer, treatment goals, and the cause of anemia. In some situations, addressing the underlying condition is the most important step. If a more detailed evaluation is needed, doctors may investigate kidney disease, bone marrow disorders, or related conditions such as leukemia depending on the broader clinical picture.

Self-care and supporting healthy red blood cell production

There is no general self-care method that directly increases erythropoietin in a safe or reliable way, and people should be cautious about products that claim otherwise. The healthiest approach is to support overall blood health and manage the conditions that affect oxygen delivery, kidney function, and nutrition.

Helpful steps may include following treatment plans for kidney, heart, or lung disease; eating a balanced diet with adequate iron, vitamin B12, and folate; staying hydrated; avoiding smoking; and keeping follow-up appointments for blood tests. People with chronic illness should ask their doctor whether they need nutritional evaluation or monitoring for anemia.

Athletic misuse of erythropoietin or related drugs should be avoided. Using these medicines without medical need or supervision can dangerously increase blood thickness and strain the heart and circulation. Safe care focuses on identifying the cause of abnormal blood counts rather than trying to change them without guidance.

When to seek medical care

Medical advice is appropriate if a person has persistent fatigue, unusual weakness, shortness of breath with normal activity, dizziness, pale skin, or a known history of kidney disease with worsening symptoms. These problems do not always mean erythropoietin is involved, but they may point to anemia or another condition that needs evaluation.

Prompt assessment is also important for symptoms that could suggest an abnormally high red blood cell count or circulation problem, such as severe headaches, chest pain, sudden shortness of breath, leg swelling, or new neurological symptoms. These symptoms need timely medical attention because they may have causes that require urgent care.

People already receiving erythropoietin-based treatment should attend regular follow-up visits and report any side effects or blood pressure changes. Near the end of the care pathway, international patients may benefit from evaluation in experienced centers; Acibadem International’s multidisciplinary specialists and JCI-accredited hospitals diagnose and treat blood, kidney, and related conditions, including therapies such as bone marrow transplantation when clinically indicated.

Frequently asked questions

What is erythropoietin in simple terms?

Erythropoietin is a hormone that tells the bone marrow to make more red blood cells. It is produced mainly by the kidneys when the body senses that oxygen levels are too low.

Why would a doctor order an erythropoietin test?

A doctor may order this test to help investigate anemia or an unusually high red blood cell count. The result can help show whether the body is making an appropriate hormone response and whether kidney, oxygen-related, or bone marrow causes should be considered.

Does low erythropoietin always mean kidney disease?

Not always, but kidney disease is one of the most common reasons. The result needs to be interpreted alongside other blood tests, symptoms, and kidney function results because several medical conditions can affect red blood cell production.

Can erythropoietin be used to treat anemia?

Yes, in selected patients, doctors may prescribe medicines that act like erythropoietin to stimulate red blood cell production. This is commonly considered in anemia related to chronic kidney disease and in some cancer-treatment settings, with regular monitoring for safety.

Are there risks with erythropoietin treatment?

Yes. If red blood cell levels rise too much, the risk of blood clots, high blood pressure, stroke, or heart-related problems can increase. That is why treatment is carefully monitored and tailored to the individual.

Can diet or supplements increase erythropoietin naturally?

Diet does not directly raise erythropoietin in a predictable way. However, good nutrition supports healthy red blood cell production, especially if iron, vitamin B12, or folate deficiencies are present.

References

  • World Health Organization
  • National Institute of Diabetes and Digestive and Kidney Diseases
  • National Heart, Lung, and Blood Institute
  • American Society of Hematology
  • Kidney Disease: Improving Global Outcomes

This article is for general information only and is not a substitute for professional medical advice. Please consult a qualified doctor about your individual situation.

Add Acıbadem on Google

Add us as a Preferred Source to see more of our trusted health content across Google Search, AI Overviews and Discover.

Share this page
Was this content helpful?
Your feedback helps us improve.
Yaren Kaya
Yaren Kaya, Anesthesia Technician
Author
View profile →
Keep Reading

More from the Health Library

Specialists

Related Specialists

We’re With You at Every Step

How can we help you today?

We value your privacy We use essential cookies to run this site and, with your consent, analytics cookies to understand how it is used and improve it. You can accept, reject, or choose what to allow. See our Cookie Policy.